JNM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH RSS TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


First published online August 17, 2007, 10.2967/jnumed.106.038646
This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
jnumed.106.038646v1
48/9/1459    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Related articles in JNM
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kas, A.
Right arrow Articles by Remy, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kas, A.
Right arrow Articles by Remy, P.
Journal of Nuclear Medicine Vol. 48 No. 9 1459-1467
© 2007 by Society of Nuclear Medicine

doi: 10.2967/jnumed.106.038646

Clinical Investigation

Validation of a Standardized Normalization Template for Statistical Parametric Mapping Analysis of 123I-FP-CIT Images

Aurélie Kas1,2, Pierre Payoux3, Marie-Odile Habert2,4, Zoulikha Malek2, Yann Cointepas5, Georges El Fakhri6, Philippe Chaumet-Riffaud7, Emmanuel Itti8 and Philippe Remy1,9

1 URA CNRS-CEA 2210, Service Hospitalier Frédéric Joliot, Orsay, France; 2 Service de Médecine Nucléaire, CHU Pitié-Salpêtrière, AP-HP, Paris, France; 3 Service de Médecine Nucléaire, CHU Purpan et INSERM U825, Toulouse, France; 4 Université Pierre et Marie Curie-Paris 6, INSERM U678, Paris, France; 5 UNAF-CEA, Service Hospitalier Frédéric Joliot, Orsay, France; 6 Nuclear Medicine Division, Radiology Department, Harvard Medical School and Brigham and Women's Hospital Boston, Massachusetts; 7 Service de Médecine Nucléaire, CHU de Bicêtre, AP-HP et Faculté de Médecine Paris 11, Le Kremlin Bicêtre, France; 8 Service de Médecine Nucléaire, CHU Henri Mondor, AP-HP et Faculté de Médecine Paris 12, Créteil, France; and 9 Département de Neurosciences, CHU Henri Mondor, AP-HP et Faculté de Médecine Paris 12, Créteil, France

Correspondence: For correspondence or reprints contact: Aurélie Kas, MD, URA CNRS-CEA 2210, Service Hospitalier Frédéric Joliot, 4, place du Général Leclerc, 91401 Orsay, France. E-mail: aurelie.kas{at}psl.aphp.fr

123I-FP-CIT (123I-N-{omega}-fluoropropyl-2ß-carbomethoxy-3ß-(4-iodophenyl)nortropane) is a SPECT dopamine transporter (DAT) tracer that probes dopaminergic cell loss in Parkinson's disease (PD). Quantification of 123I-FP-CIT images is performed at equilibrium using a ratio (BR) of specific (striatal) to nonspecific (occipital) uptake with values obtained from regions of interest drawn manually over these structures. Statistical parametric mapping (SPM) is a fully automated voxel-based statistical approach that has great potential in the context of DAT imaging. However, the accuracy of the spatial normalization provided by SPM has not been validated for 123I-FP-CIT images. Our first aim was to create an 123I-FP-CIT template that does not require the acquisition of patient-specific MRI and to validate the spatial normalization procedure. Next, we hypothesized that this customized template could be used by different SPECT centers without affecting the outcomes of imaging analyses. Methods: The spatial normalization to the customized template created with SPM (template A1) was validated using 123I-FP-CIT images obtained from 6 subjects with essential tremor (ET) with normal DAT status and 6 PD patients. Variability in BR values due to the normalization was evaluated using striatal volume of interest (VOI). To determine whether different SPECT centers could use a unique 123I-FP-CIT template, we generated 3 other 123I-FP-CIT templates using different subjects and image-processing schemes. The interchangeability of these templates was assessed using (a) putamen BR values analyzed with the intraclass correlation coefficient (ICC) and the Bland–Altman graphical analysis, and (b) SPM analysis comparing the results of group comparisons—that is, ET versus PD, obtained after normalization to each of the 4 templates. Results: There was no significant difference between pre- and postnormalization striatal BR values in our study. The mean variability calculated with putamen VOI values after normalization to each template was <10%, with the lowest ICC of 98%. Intergroup analyses performed with VOI and SPM approaches provided similar results independently of the template used. Conclusion: SPM normalization was accurate even in subjects with low striatal 123I-FP-CIT uptake, making it a promising approach for automatic analysis of 123I-FP-CIT images using a single customized template at different centers.

Key Words: dopamine transporters • SPECT • statistical parametric mapping • normalization • Parkinson's disease

COPYRIGHT © 2007 by the Society of Nuclear Medicine, Inc.


Related articles in JNM:

This Month in JNM

JNM 2007 48: 11A-12A. [Full Text]  






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH RSS TABLE OF CONTENTS
JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY THE JOURNAL OF NUCLEAR MEDICINE
Copyright © 2007 by the Society of Nuclear Medicine.